05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations; medicines and natural remedies;
diagnostic preparations and materials for medical and
veterinary purposes; sanitary preparations and articles.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
Pharmaceutical preparations; medicines and natural remedies;
diagnostic preparations and materials for medical and
veterinary purposes; sanitary preparations and articles.
3.
COMPOUNDS FOR ELECTRONIC DEVICES, IN PARTICULAR COMPOUNDS FOR OLEDS
The present invention relates to ADCs binding to NaPi2b comprising exatecan and a beta-glucuronidase cleavable linker, the ADCs being prepared by transglutaminase conjugation.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
An integrated showerhead-filtration system for a precursor container is disclosed. The integrated showerhead-filtration system may include an annular-shaped filtration medium, a diverter, and a showerhead. A lower side of the annular-shaped filtration medium may engage a top side of the diverter, and the bottom side of the diverter may engage an upper end of the showerhead. A carrier gas may be passed through a first aperture of the annular-shaped filtration medium, through a neck of the diverter and into a first-annularly-shaped-chamber, and through a bore of the showerhead into a hollow of the precursor container storing a precursor material, thereby creating a mixture of carrier gas and precursor material. The mixture may be passed through a port of the diverter into a second-annularly-shaped-chamber and through the annular-shaped filtration medium to create a filtered carrier gas-precursor material mixture.
C23C 16/44 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
C23C 16/448 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for generating reactive gas streams, e.g. by evaporation or sublimation of precursor materials
42 - Scientific, technological and industrial services, research and design
Goods & Services
Platform as a service (PaaS) for pharmaceutical and
biopharmaceutical testing and manufacturing services;
software as a service [SaaS] for pharmaceutical and
biopharmaceutical testing and manufacturing services;
providing temporary use of online non-downloadable software
for pharmaceutical and biopharmaceutical testing and
manufacturing services; software maintenance services for
pharmaceutical and biopharmaceutical testing and
manufacturing services.
Mono or bi-specific antibodies, antibody fragments, or fusion proteins thereof, are capable of binding to the VHL ligand degrading moiety (degron) of a proteolysis targeting chimera (PROTAC) and, optionally, to a target protein. Complexes (PAX) of such antibodies, antibody fragments, fusion proteins thereof, and PROTACS are also capable of. Methods for their production can be performed, and these antibodies have medical and non-medical uses.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
C07K 16/28 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
C07K 16/30 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Method (100) configured to laminate a liquid fluid cell (1) to a substrate (6), particularly a glass substrate, the method (100) comprising the steps of: - arranging(110) at least one liquid fluid cell (1) comprising at least a first cell substrate (15) and a second cell substrate (15) spaced such to form a cell gap (16) comprising a fluid, particularly a liquid crystal material, with at least one substrate (6) and at least one lamination layer (7); - a laminating (120) of the substrate (6) to the liquid fluid cell (1) via at least one of the first cell substrate (15) or the second cell substrate (15) using the lamination layer (7), characterized by at least two of the following steps, particularly performed temporarily overlapping or simultaneously: - a degassing and/or gas dissolving; - applying (130) a controlled pressing, particularly applying a low pressure for a defined timespan; - applying (140) a controlled thermal load; - applying (150) an even distribution of pressure over the liquid fluid cell (1); and - applying (160) an even distribution of temperature over the liquid fluid cell (1).
B32B 17/10 - Layered products essentially comprising sheet glass, or fibres of glass, slag or the like comprising glass as the main or only constituent of a layer, next to another layer of a specific substance of synthetic resin
(7-{1H,2H,3H-PYRIDO [2,3-B][1,4]OXAZIN-7-YL}-5H,6H,7H,8H-PYRIDO[3,4-D]PYRIMIDIN-2-YL)AMINE DERIVATIVES AS BIFUNCTIONAL DEGRADERS OF HPK1 FOR THE TREATMENT OF CANCER
The present invention relates to compounds of the formula (I) that are potent degraders or inhibitors of hematopoietic progenitor kinase 1 (HPK1). The compounds are useful to treat or prevent cancer and/or inflammatory and/or autoimmune diseases or symptoms thereof.
A61P 37/00 - Drugs for immunological or allergic disorders
A61P 29/00 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agentsNon-steroidal antiinflammatory drugs [NSAID]
10.
COMBINATION OF RACK FOR HOLDING A PLURALITY OF SETTLE PLATES AND BRACKET, UNIT/MODULE AND METHOD FOR BIDIRECTIONAL TRANSFER OF SETTLE PLATES TO/FROM CLEANROOM ENVIRONMENT
The present application relates to a combination of a rack for holding a plurality of settle plates and a bracket and to a unit/module, and a method for bidirectional transfer of settle plates to and/or from a cleanroom environment through a sterile transfer port.
A method for selectively passivating a surface of a substrate, wherein the surface of the substrate includes at least a first surface comprising a dielectric and at least a second surface comprising another dielectric material or metal. The method includes the step of exposing the first and second surfaces to at least one the organoamino-alkoxysilane selectively reacts with the dielectric to passivate the first surface thereby leaving the second surface substantially unreacted.
H01L 21/32 - Treatment of semiconductor bodies using processes or apparatus not provided for in groups to form insulating layers thereon, e.g. for masking or by using photolithographic techniquesAfter-treatment of these layersSelection of materials for these layers using masks
H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof
12.
PROCESS FOR MANUFACTURING (S)-3-HYDROXY-1-(1H-INDOL-5-YL)-2-OXO-PYRROLIDINE-3-CARBOXYLIC ACID 3,5-DIFLUORO-BENZYLAMIDE
C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
13.
APPARATUS AND PROCESS FOR HANDLING AN EQUIPMENT-TRAY ASSEMBLY
The present invention relates to an apparatus and a process for handling an equipment-tray assembly. The present invention in particular concerns the fields of bioburden testing, water testing, pharmaceutical, cosmetics, food processing, semiconductor production, electronics, and environmental monitoring of closed processing areas.
The present application relates to a jig for aiding manual piercing of a liquid extraction needle or pipette tip into a septum of a vial cap, to a vial adapter including the jig, and to a method of extracting a liquid from a vial using the jig, allowing in comparison to existing solutions a significant reduction in the need of generally petroleum-based polymers in production, transport and storage.
The present application relates to an automated sampling device, particularly an environmental sampling device adapted to cooperate with or including a particle monitoring system where the sampling section for performing a sampling process on a sample fluid, preferably a gas, such as air, comprises a particle sampler or collector device and/or a particle counter device.
The present application relates to an electronic device comprising a first electrode, a second electrode facing the first electrode, an interlayer between the first electrode and the second electrode comprising a hole transport region comprising at least two hole- transporting layers. The present application also relates to an OLED material.
A liquid-crystal (LC) material having negative dielectric anisotropy and the use thereof for optical, electro-optical and electronic purposes, such as for example in energy-efficient LC displays, in particular displays based on the electrically controlled birefringence (ECB), IPS, or FFS effect.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfacesMaterials therefor, e.g. comprising photoresistsApparatus specially adapted therefor
G03F 7/027 - Non-macromolecular photopolymerisable compounds having carbon-to-carbon double bonds, e.g. ethylenic compounds
G03F 7/105 - Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers having substances, e.g. indicators, for forming visible images
The present invention relates to an organic light-emitting device in which a specific combination of different OLED materials, in particular a combination of a hole transport material and a p-dopant in a hole injection layer, a hole transport material in a hole transport layer, and a host material in the emitting layer is used.
An automated inspection system (2) for containers (6) of different size and weight, comprising of at least one digital camera system (5) which can be mounted in different positions, a rotatable platform (3) for positioning the containers (6) so they can be scanned by the at least one digital camera system (5), wherein either the at least one digital camera system (5) or the rotatable platform (3) or both are adjustable in height, a container transport system (7) which transports the containers (6) to the platform (3), a computer (4) which is connected to the at least one digital camera system (5) and which has access to a database and a software (8) performed by the computer (4) which analyzes digital images (10) taken by the at least one digital camera system (5) and determines the quality of the scanned container (6).
The present invention relates to an indene derivative of formula D as specified in claim 1, to a liquid crystal medium comprising a compound of formula D and to high- frequency components comprising these media, especially microwave components for high-frequency devices, such as devices for shifting the phase of microwaves, tunable filters, tunable metamaterial structures, and electronic beam steering antennas, e.g. phased array antennas.
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
C09K 19/18 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a carbon chain the chain containing carbon-to-carbon triple bonds, e.g. tolans
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
22.
A SEMI-AUTOMATIC SEGMENTATION SYSTEM FOR PARTICLE MEASUREMENTS FROM MICROSCOPY IMAGES
Disclosed is a method of computer-based small particle measurement for drug formulation in which digital microscopy images of the small particles used for drug formulation are created by an image sensor and provided to a computer performing a measurement software. The software segments the small particles in the digital microscopy images and calculates properties thereof, according to specific parameter sets. The software samples different candidate parameter sets, applies them automatically for the segmentation and/or calculation process, and shows the results via a display to a user. The user picks the a candidate parameter set with the best results, and the software establishes and trains an internal machine learning model with this user feedback. The software then applies the trained model to reiterate the automatic segmentation and/or calculation and user feedback obtaining process until an optimal parameter set is approved by the user.
G06V 20/69 - Microscopic objects, e.g. biological cells or cellular parts
G01N 23/2251 - Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups , or by measuring secondary emission from the material using electron or ion microprobes using incident electron beams, e.g. scanning electron microscopy [SEM]
G01N 33/94 - Chemical analysis of biological material, e.g. blood, urineTesting involving biospecific ligand binding methodsImmunological testing involving narcotics
G06F 18/40 - Software arrangements specially adapted for pattern recognition, e.g. user interfaces or toolboxes therefor
23.
CYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to cyclic compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
H10K 85/60 - Organic compounds having low molecular weight
C07B 59/00 - Introduction of isotopes of elements into organic compounds
C07C 211/54 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
C07C 211/60 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton containing a ring other than a six-membered aromatic ring forming part of at least one of the condensed ring systems
C07D 209/86 - CarbazolesHydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
C07D 209/94 - [b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
C07D 239/26 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
C07D 239/28 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
C07D 239/74 - QuinazolinesHydrogenated quinazolines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to ring carbon atoms of the hetero ring
C07D 241/42 - Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
C07D 251/24 - Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
C07D 403/04 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 403/10 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
C07D 403/14 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing three or more hetero rings
C07D 405/04 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 405/10 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
C07D 409/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring- member bond
The present invention relates to a liquid-crystal (LC) material as defined in claim 1, having negative dielectric anisotropy and to the use thereof for optical, electro-optical and electronic purposes, such as for example in LC displays, in particular energy efficient displays based on the ECB, IPS or FFS effect.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
A polysiloxane composition having a repeating unit represented by the following formula (Ia) as defined herein is used to improve the exposure sensitivity of a metal oxide resist.
G03F 7/11 - Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers having cover layers or intermediate layers, e.g. subbing layers
The present invention relates to liquid-crystalline (LC) media or LC materials and to energy saving liquid-crystal displays (LCDs) containing these media, especially to gaming displays and AR/VR headsets addressed by an active matrix and in particular to LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB- FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
The present invention relates to a curable composition, preferably being a photo-curable composition, comprising at least a 1st monomer compound and a polymerization initiator.
C08F 212/34 - Monomers containing two or more unsaturated aliphatic radicals
C08F 212/32 - Monomers containing only one unsaturated aliphatic radical containing two or more rings
C07C 13/34 - Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with a bicyclo ring system containing four carbon atoms
C09D 11/101 - Inks specially adapted for printing processes involving curing by wave energy or particle radiation, e.g. with UV-curing following the printing
C09D 125/02 - Homopolymers or copolymers of hydrocarbons
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfacesMaterials therefor, e.g. comprising photoresistsApparatus specially adapted therefor
H01L 21/02 - Manufacture or treatment of semiconductor devices or of parts thereof
42 - Scientific, technological and industrial services, research and design
Goods & Services
Scientific laboratory services; Laboratory research in the field of automated drug discovery; Laboratory testing of materials; Chemical research and analysis; Biological research and analysis; Scientific research and development; Research and development of new products; Research and development of new products for others; Drug discovery services; Testing of chemicals; Technological research in the field of and relating to the application of artificial intelligence and automated robotic process in the fields of scientific research, laboratory services, and drug discovery; Development of new technology for others in the field of and relating to the application of artificial intelligence and automated robotic process in the fields of scientific research, laboratory services, and drug discovery; Platform as a service (PAAS) featuring computer software platforms for data analysis, data management, molecular design, and retrosynthesis in the fields of scientific research and laboratory services; Design and development of computer software for scientific research, laboratory services, and drug discovery
29.
ALIGNMENT PROCESS FOR A SINGLE MOLECULE DETECTION INSTRUMENT
A Method and a system for aligning the optical components of a fiber- coupled, single molecule detection instrument for detecting protein concentrations in a prepared assay solution consisting of several components, the system comprising a digital autocollimator alignment telescope to thereby measure reference mirror angle and beam divergence, angle, and position, an instrument alignment frame to thereby constrain the instrument optical frame during the alignment procedure, a DeMux sorter focusing jig to thereby focus detector lenses in the DeMux sorter, objective inserts installed in place of objectives during the alignment procedure and multiple backlights and targets to thereby perform the optical element alignments.
A Method and a System for integrating at least two software-based models in a Target Digital Twin simulating a bioprocess via a computer, comprising the following steps of A Standardized Model Integration Step wherein a common ontology is defined by a user for the Target Digital Twin including the at least two software-based models; A Data Integration Step wherein the computer uses the ontology to facilitates the integration of heterogeneous data from various sources and the at least two software-based models; After these two steps a Data Mapping Step wherein the computer maps the ontology-integrated at least two software-based models to the designated bioprocess; An Inter-model Communication Step wherein the computer uses the ontology to exchange data about the Bioprocess between the at least two software-based models; A Simulation and Analysis Step, wherein the computer uses the ontology to align the at least two software-based models regarding their computations, inputs, and outputs to facilitate the integration of the at least two software-based models into an end-to-end simulation of the bioprocess in form of the Digital Twin; and An Application Step of using the Digital Twin to simulate the bioprocess and its respective hardware instruments and optimize the hardware instruments and/or process settings with the respective simulation results.
G06F 30/20 - Design optimisation, verification or simulation
G16B 5/00 - ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
31.
N-HETEROCYCLIC CARBENE TRANSITION METAL COMPOUNDS AND THEIR APPLICATION IN CATALYSIS
Provided is a new class of ionic N-heterocyclic carbene (NHC) transition metal compounds, which can be prepared by easily scalable synthetic routes with excellent yields and purities. The ionic NHC-transition metal compounds show high catalytic activity and high reaction efficiency in various transition metal-catalyzed reactions. There are further provided facile and scalable processes for synthesizing said ion c NHC-transition metal compounds and there are provided methods for performing transition metal-catalyzed reactions using said ionic NHC-transition metal compounds as precatalysts.
LC media exhibiting a ferroelectric nematic phase at ambient temperature, comprising at least one or more compounds of formula IA having at least five rings,
LC media exhibiting a ferroelectric nematic phase at ambient temperature, comprising at least one or more compounds of formula IA having at least five rings,
LC media exhibiting a ferroelectric nematic phase at ambient temperature, comprising at least one or more compounds of formula IA having at least five rings,
The mixtures are useful for electro-optics, electronics, electro-mechanic and other applications for materials with very high dielectric permittivity.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
G02F 1/135 - Liquid crystal cells structurally associated with a photoconducting or a ferro-electric layer, the properties of which can be optically or electrically varied
A liquid-crystal (LC) medium or liquid-crystal (LC) materials based on a mixture of polar compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode and/or the fringe-field switching mode, an LC display of the vertically aligned mode and/or the fringe-field switching mode comprising the LC medium, especially an energy-efficient LC display, and a process of manufacturing the LC display.
G02F 1/13 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
G02F 1/1337 - Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
A crosslinked polysilazane includes a repeating unit represented by the formula (1) as defined herein:
A crosslinked polysilazane includes a repeating unit represented by the formula (1) as defined herein:
C09D 183/16 - Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon onlyCoating compositions based on derivatives of such polymers in which all the silicon atoms are connected by linkages other than oxygen atoms
C09D 183/14 - Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon onlyCoating compositions based on derivatives of such polymers in which at least two but not all the silicon atoms are connected by linkages other than oxygen atoms
35.
SPIROBIFLUORENE COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
C07C 211/61 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
C07C 211/54 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to two or three six-membered aromatic rings
C07D 209/86 - CarbazolesHydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
C07D 209/88 - CarbazolesHydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
C07D 265/38 - [b, e]-condensed with two six-membered rings
C07D 279/22 - [b, e]-condensed with two six-membered rings with carbon atoms directly attached to the ring nitrogen atom
The invention relates to HER2 targeting Fc antigen binding fragment-drug conjugates (HER2 Fcab-drug conjugates) and the use of the HER2 Fcab-drug conjugates of the present invention for the treatment and/or prevention of hyperproliferative diseases and disorders in mammals, especially humans, and pharmaceutical compositions containing such HER2 Fcab-drug conjugates. Further, the invention relates to HER2 Fcab-label conjugates and diagnostic compositions containing such HER2 Fcab-label conjugates.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
C07K 16/32 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products from oncogenes
37.
SYSTEM AND METHOD FOR CONTINUOUS BIOPROCESSING SIMULATION
The present disclosure relates to a system and method for continuous bioprocessing simulation utilizing parameterized and pre-validated model components. The system selects validated equations from a catalogue to construct modular unit operation models, which are then instantiated into configured instances. These instances are interconnected into an integrated flowsheet simulation, which is co-simulated to capture the transient behavior of components with different time constants. The parametrized, modular modeling approach enables rapid and robust simulation of continuous biopharmaceutical production processes by assembling simulations from pre-qualified building blocks. This facilitates efficient digital prototyping and analysis of integrated continuous bioprocess systems.
A polymeric biocontainer having a polymeric front panel, a polymeric back panel, a polymeric top panel, a polymeric bottom panel, and two polymeric side panels, wherein the front panel, the back panel, the top panel, the bottom panel, and the two side panels have the same length and height dimensions and are bonded together, wherein the front panel, the back panel, the top panel, the bottom panel, and the two side panels are joined to form eight comer joints to create an internal volume.. Methods for forming the polymeric biocontainer are also disclosed.
C12M 1/00 - Apparatus for enzymology or microbiology
B65D 6/00 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor
B65D 6/16 - Containers having bodies formed by interconnecting or uniting two or more rigid, or substantially rigid, components made wholly or mainly of metal, plastics, wood or substitutes therefor collapsible
39.
NITROGEN-CONTAINING COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to nitrogen-containing compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices containing said compounds.
C07D 405/14 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
H10K 50/11 - OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
H10K 85/60 - Organic compounds having low molecular weight
40.
NITROGEN-CONTAINING HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to nitrogen-containing heterocycles that are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing these heterocycles.
The invention relates to materials that are suitable for use in electronic devices and to electronic devices, in particular organic electroluminescent devices, containing said materials.
A liquid-crystal (LC) medium (as a subcategory of liquid crystal material), based on a mixture of polar compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode, an LC display of the vertically aligned mode comprising the LC medium, especially an energy-saving LC display, and a process of manufacturing the LC display.
G02F 1/137 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
The present invention relates to a composition comprising a electron-transporting host material, a phosphorescent emitter as a sensitizer and a fluorescent emitter, as well as devices comprising these compositions, especially organic electroluminescent devices including an emission layer comprising these compositions.
A material for an organic electronic device includes at least one compound of Formula (1) as described herein. An organic electronic device includes an anode, a cathode and at least one organic layer that includes at least one such compound.
The glycosylation profile of a biologic molecule describes important aspects of such biologic molecule. The characterization of the glycosylation profile of a biologic molecule is an important part of the critical quality attributes in the manufacturing and analytical processes for biologic molecules. As such described herein are methods to determine and characterize the glycosylation profile of a biologic molecule. In particular, the method uses one or more indices to describe the glycosylation profile as a finger-print of such biologic molecule.
The present invention relates to compounds of formula (I) and stereoisomers, tautomers, N-ox-ides, or pharmaceutically acceptable salts thereof that are useful for modulating flap endonucle-ase (FEN1). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
NN-ox- ides, and pharmaceutically acceptable salts thereof that are useful for modulating exonuclease 1 (EXO1). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds.
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
09 - Scientific and electric apparatus and instruments
11 - Environmental control apparatus
35 - Advertising and business services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Chemicals used in industry, science and photography, as well
as in agriculture, horticulture and forestry; unprocessed
artificial resins, unprocessed plastics; manures; fire
extinguishing compositions; tempering and soldering
preparations; chemical substances for preserving foodstuffs;
tanning substances; adhesives used in industry; filtering
media of chemical and non-chemical substances; chemical
preparations and materials for use in film, photography and
printing; adhesives for use in industry; detergents for use
in manufacture and industry; chemical substances, chemical
materials and chemical preparations and organic compositions
for use in manufacturing processes, including compositions
for fire extinguishing and prevention, chemical compositions
and materials for use in science, chemical compositions and
materials for use in cosmetics, chemical compositions for
use in construction, chemical compositions for water
treatment, chemical and organic compositions and substances
for treatment of leather and textiles; salts for industrial
purposes; unprocessed and synthetic resins; starch for use
in manufacture and industry; chemical and organic
compositions for use in the manufacture of food and
beverages. Pharmaceutical, medical and veterinary preparations;
sanitary preparations for medical purposes; dietetic food
and products for medical or veterinary use, food for babies;
dietary supplements for humans and animals; plasters,
materials for dressings; material for stopping teeth, dental
wax; disinfectants; preparations for destroying vermin;
fungicides, herbicides; dietary supplements and dietetic
preparations, including dietary supplements for animals;
dental preparations and articles; hygienic preparations and
articles, including disinfectants and antiseptics,
deodorizers and air purifying preparations, absorbent
articles for personal hygiene; pest control preparations and
articles; medical and veterinary preparations, including
diagnostic preparations, pharmaceuticals and natural
remedies, medical dressings. Light emitting diodes; solar batteries; solar panels for
generating electricity; semiconductor devices and liquid
crystal displays; chromatography apparatus and instruments
for laboratory, research and scientific use; filters and
filtering units for laboratory, research and scientific use;
test kits comprising apparatus and instruments for
laboratory, research and scientific use; bioreactors for
laboratory use; bioreactors for research use; storage
containers for laboratory chemicals other than for medical
or veterinary purposes; car antennas; television antennas;
satellite antennas; radar antennas; radio antennas; Internet
of Things range extenders and antennas; antennas for
wireless communication apparatus; display screen components;
flat panel displays, including thin-film-transistor liquid
crystal displays, light emitting diodes, photovoltaic,
micro-electro-mechanical and other electronic components;
spectrometers for non-medical purposes; silicon wafers;
structured semiconductor wafers; software applications for
mobile devices; downloadable software applications for
mobile devices; radio-frequency identification (RFID) tags;
radio-frequency identification (RFID) readers;
identification labels [encoded]; identification labels
[machine-readable]; identification labels [magnetic];
electronic controllers and software for monitoring,
handling, supplying and dispensing chemicals, chemical
compositions, chemical mechanical planarization slurries,
chemical residue removal solutions, gases and materials in
the electronics, semiconductor and microelectromechanical
industries; electrical process control equipment for use in
the electronics, semiconductor and micro-electro-mechanical
industries for the production of electronic devices, namely,
logic circuits, memory modules, sensors, discrete components
[electronic circuit element], asynchronous and analog
semiconductor devices. Semiconductor processing furnaces for processing
semiconductor products; optical films as components of
illumination equipment and illumination devices; water
purifying apparatus for biochemical use. Advertising; business management; business administration;
office functions; marketing and promotional services,
including public relations services, product demonstrations
and product display services, distribution of advertising,
marketing and promotional material, digital advertising
services; import and export agency services; business
analysis, research and information services, including
market research, collection and systematization of business
data; consultancy and information on the aforesaid. Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; design and development of computer hardware and
software; hosting services and software as a service and
rental of software, including hosting of digital content on
the internet; scientific and technological services,
including medical and pharmacological research services;
testing, authentication and quality control; consultancy and
information on the aforesaid. Medical services; veterinary services; hygienic and beauty
care for human beings or animals; agriculture, horticulture
and forestry services; animal healthcare services; human
healthcare services, including medical services, dentistry
services, pharmaceutical services, opticians' services,
mental health services; consultancy and information on the
aforesaid.
52.
SPIRAL WOUND FILTRATION DEVICE AND METHODS OF MANUFACTURE
A spiral wound membrane module, comprising a perforated core having an axially extending internal bore; at least one membrane packet comprising a folded membrane sheet defining a first outer face, a first inner face, a second outer face and a second inner face, the fold of the folded membrane sheet being a leading end of the membrane packet; a feed sheet positioned between the first and second inner faces so as to be sandwiched by the folded membrane sheet; a first permeate screen adjacent the first outer face of the membrane sheet defining a first permeate channel; a second permeate screen adjacent the second outer face of the membrane sheet defining a second permeate channel; and a fluid impermeable support coupled to the leading edge of the membrane packet. Also disclosed is a method of manufacturing the spiral wound membrane module.
The present invention relates to a formulation for preparing an optical layer containing a metal oxide or mixture of metal oxides. The formulation may exhibit at least one of properties as an advanced material or as a high-performance material. The formulation may be used in the nanotechnology process to make semiconductor device/display device application, for example a Liquid crystal display (LCD), Light emitting diode display (LED display), organic light emitting display (OLED), micro-LED display, quantum dot display (QLED), AR display, VR display, MR display, plasma (PDP) display, electroluminescent (ELD) display fabricated on a substrate controlled by semiconductors.
C23C 18/12 - Chemical coating by decomposition of either liquid compounds or solutions of the coating forming compounds, without leaving reaction products of surface material in the coatingContact plating by thermal decomposition characterised by the deposition of inorganic material other than metallic material
54.
SOLUTION PREPARATION DEVICE, SOLUTION PREPARATION SYSTEM, AND METHOD OF PREPARING A SOLUTION USING THE SOLUTION PREPARATION SYSTEM
The present application relates to a solution preparation device, a solution preparation system and a method of preparing a solution using the solution preparation system. The present application particularly relates to an automated solution preparation device, system and method, in particular for preparing a solution like a buffer, for use in chemical, biochemical and biological applications.
The invention provides antibodies which bind human GD2 protein, as well as isolated nucleic acids and host cells comprising a sequence encoding said antibodies. The invention also provides immunoconjugates comprising said antibodies linked to a growth-inhibitory agent, and pharmaceutical compositions comprising antibodies or immunoconjugates of the invention. The invention also provides use of the antibodies, immunoconjugates and pharmaceutical compositions of the invention for the treatment of cancer or for diagnostic purposes.
A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additivesTargeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
The disclosed and claimed subject matter relates to a method for depositing tin-containing films that includes the steps of (a) contacting a substrate with organotin alkoxide precursor vapor in a deposition reactor, (b) thereafter introducing an organotin amide precursor vapor in a deposition reactor wherein the organo group is different from the organo group in the organotin alkoxide precursor, (c) purging the reactor vessel with inert gas, (d) contacting the substrate with a water-containing vapor to form an organotin oxo network layer, (e) purging the reactor vessel with inert gas.
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
C23C 16/44 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating
The present invention relates to a composition comprising components a), b) and c). The component a) is a block copolymer or a blend of block copolymers. The component b) is a low Tg additive selected from the group consisting of an oligo random oligo random copolymer b-1), an oligo diblock copolymer b-2), an oligo diblock copolymer b-3) and a mixture of at least two of these. The component c) is a is a spin casting organic solvent. The invention also pertains to the use of said compositions in directed self-assembly. The invention further pertains to the novel oligo diblock copolymer b-2) which is an oligo diblock copolymer of block A-b) and block B-b), wherein
block A-b) is a random copolymer of repeat units having structures (III), and (IV and
block B-b) is a random copolymer of repeat units having structures (V), and (VI).
The present invention relates to a composition comprising components a), b) and c). The component a) is a block copolymer or a blend of block copolymers. The component b) is a low Tg additive selected from the group consisting of an oligo random oligo random copolymer b-1), an oligo diblock copolymer b-2), an oligo diblock copolymer b-3) and a mixture of at least two of these. The component c) is a is a spin casting organic solvent. The invention also pertains to the use of said compositions in directed self-assembly. The invention further pertains to the novel oligo diblock copolymer b-2) which is an oligo diblock copolymer of block A-b) and block B-b), wherein
block A-b) is a random copolymer of repeat units having structures (III), and (IV and
block B-b) is a random copolymer of repeat units having structures (V), and (VI).
C08L 53/00 - Compositions of block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bondsCompositions of derivatives of such polymers
C08F 297/02 - Macromolecular compounds obtained by successively polymerising different monomer systems using a catalyst of the ionic or coordination type without deactivating the intermediate polymer using a catalyst of the anionic type
C09D 153/00 - Coating compositions based on block copolymers containing at least one sequence of a polymer obtained by reactions only involving carbon-to-carbon unsaturated bondsCoating compositions based on derivatives of such polymers
G03F 7/00 - Photomechanical, e.g. photolithographic, production of textured or patterned surfaces, e.g. printed surfacesMaterials therefor, e.g. comprising photoresistsApparatus specially adapted therefor
G03F 7/36 - Imagewise removal not covered by groups , e.g. using gas streams, using plasma
H01L 21/027 - Making masks on semiconductor bodies for further photolithographic processing, not provided for in group or
The present invention relates to specifically substituted deuterated biscarbazoles as OLED materials, to mixtures containing them, to the use thereof in organic electronic devices and to organic electronic devices containing these compounds, in particular organic electroluminescent devices or OLEDs containing these compounds as matrix materials, hole-transport materials, hole-injection materials or electron-blocking materials.
C07D 405/04 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring- member bond
C07D 405/10 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
Liquid-crystalline (LC) media having positive dielectric anisotropy and liquid-crystal displays (LCDs) containing these media, especially displays addressed by an active matrix and in particular energy efficient LC displays of the TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability against UV radiation and elevated temperatures.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
The hereby described invention discloses a system and a method to determine suitable co-compound combinations via a combined software based approach of first principle calculations and a machine learning.
Heterobifunctional compounds of the formula (I) are provided that are potent degraders or inhibitors of hematopoietic progenitor kinase 1 (HPK1). The compounds are useful to treat or prevent cancer and/or inflammatory and/or autoimmune diseases or symptoms thereof in mammals, particularly humans.
C07D 519/00 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or
01 - Chemical and biological materials for industrial, scientific and agricultural use
05 - Pharmaceutical, veterinary and sanitary products
09 - Scientific and electric apparatus and instruments
11 - Environmental control apparatus
35 - Advertising and business services
42 - Scientific, technological and industrial services, research and design
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services
Goods & Services
Chemicals used in industry, science and photography, as well
as in agriculture, horticulture and forestry; unprocessed
artificial resins, unprocessed plastics; manures; fire
extinguishing compositions; tempering and soldering
preparations; chemical substances for preserving foodstuffs;
tanning substances; adhesives used in industry; filtering
media of chemical and non-chemical substances; chemical
preparations and materials for use in film, photography and
printing; adhesives for use in industry; detergents for use
in manufacture and industry; chemical substances, chemical
materials and chemical preparations and organic compositions
for use in manufacturing processes, including compositions
for fire extinguishing and prevention, chemical compositions
and materials for use in science, chemical compositions and
materials for use in cosmetics, chemical compositions for
use in construction, chemical compositions for water
treatment, chemical and organic compositions and substances
for treatment of leather and textiles; salts for industrial
purposes; unprocessed and synthetic resins; starch for use
in manufacture and industry; chemical and organic
compositions for use in the manufacture of food and
beverages. Pharmaceutical, medical and veterinary preparations;
sanitary preparations for medical purposes; dietetic food
and products for medical or veterinary use, food for babies;
dietary supplements for humans and animals; plasters,
materials for dressings; material for stopping teeth, dental
wax; disinfectants; preparations for destroying vermin;
fungicides, herbicides; dietary supplements and dietetic
preparations, including dietary supplements for animals;
dental preparations and articles; hygienic preparations and
articles, including disinfectants and antiseptics,
deodorizers and absorbent articles for personal hygiene;
pest control preparations and articles; medical and
veterinary preparations, including diagnostic preparations,
pharmaceuticals and natural remedies, medical dressings,
cover sheets and applicators. Light emitting diodes; solar batteries; solar panels for
generating electricity; semiconductor devices and liquid
crystal displays; chromatography apparatus and instruments
for laboratory, research and scientific use; filters and
filtering units for laboratory, research and scientific use;
test kits comprising apparatus and instruments for
laboratory, research and scientific use; bioreactors for
industrial use; car antennas; television antennas; satellite
antennas; radar antennas; radio antennas; Internet of Things
range extenders and antennas; antennas for wireless
communication apparatus; glass with an electrically
conductive surface, glass panes incorporating fine
electrical conductors; screen components; flat panel
displays, including thin-film-transistor liquid crystal
displays, light emitting diodes, photovoltaic,
micro-electro-mechanical and other electronic components;
spectrometers for non-medical purposes; silicon wafers;
structured semiconductor wafers; software applications for
mobile devices; downloadable software applications for
mobile devices; radio-frequency identification (RFID) tags;
radio-frequency identification (RFID) readers;
identification labels [encoded]; identification labels
[machine-readable]; identification labels [magnetic];
electronic controllers and software for monitoring,
handling, supplying and dispensing chemicals, chemical
compositions, chemical mechanical planarization slurries,
chemical residue removal solutions, gases and materials in
the electronics, semiconductor and micro-electro-mechanical
industries; electrical process control equipment for use in
the electronics, semiconductor and micro-electro-mechanical
industries for the production of electronic devices, namely,
logic circuits, memory modules, sensors, discrete components
[electronic circuit element], asynchronous and analog
semiconductor devices. Semiconductor processing furnaces for processing
semiconductor products; apparatus for rinsing and drying
wafers; optical films as components of illumination
equipment and illumination devices; water purifying
apparatus for biochemical use; air purifiers. Advertising; business management; business administration;
office functions; marketing and promotional services,
including public relations services, product demonstrations
and product display services, distribution of advertising,
marketing and promotional material, digital advertising
services; import and export agency services; business
analysis, research and information services, including
market research, collection and systematization of business
data; consultancy and information on the aforesaid. Scientific and technological services and research and
design relating thereto; industrial analysis and research
services; design and development of computer hardware and
software; hosting services and software as a service and
rental of software, including hosting of digital content on
the Internet; scientific and technological services,
including medical and pharmacological research services;
testing, authentication and quality control; consultancy and
information on the aforesaid. Medical services; veterinary services; hygienic and beauty
care for human beings or animals; agriculture, horticulture
and forestry services; animal healthcare services; human
healthcare services, including medical services, dentistry
services, pharmaceutical services, opticians' services,
mental health services; consultancy and information on the
aforesaid.
63.
GENERATION OF ON-DEMAND SOFTWARE BASED MODELS FOR PRODUCTION PROCESS APPLICATIONS
Method for establishing and calibrating a on-demand software-based model for simulating a production process via a software-based Model Builder Module on a computer, wherein the Model Builder Module is connected to an ontology database that contains different domains, such as a bioprocessing data domain, a numeric simulation domain, and a mathematical model domains for the Model Builder Module, comprising the following steps of Defining the goal of the software based model, including information about the process the model describes, in particular process steps, cell line, molecule produced, variables the model predicts and threshold values of required model quality indicators; Selecting experimental data required for the calibration and the validation of the model in form of a list of experiments selectable in the Model Builder Module, wherein the context of the experiment data, which is stored in the ontology database matches the defined goal of the model; Composing the software-based model using the toolset proposed by the Model Builder Module which is specific to the respective process step the model describes; Calibrating the created software-based model with provided experimental data via the Model Builder Module; and Checking the validity and quality of the software-based model by performing a quality check of the Model using different mathematical analysis.
G05B 17/02 - Systems involving the use of models or simulators of said systems electric
G06Q 10/04 - Forecasting or optimisation specially adapted for administrative or management purposes, e.g. linear programming or "cutting stock problem"
G06F 119/18 - Manufacturability analysis or optimisation for manufacturability
G06F 30/20 - Design optimisation, verification or simulation
G06F 30/27 - Design optimisation, verification or simulation using machine learning, e.g. artificial intelligence, neural networks, support vector machines [SVM] or training a model
An improved electro-mechanical principle for converting electric power into mechanical action and vice versa using dielectrics with extreme relative permittivity. The non-magnetic devices are based on relative movement of dielectrics in the presence of electric fields. The energy-saving devices use high-performance dielectrics based on ferroelectric nematic liquid crystals. Linear and circular mechanical action is proposed involving electromechanical actuators, non-magnetic motors and related electrical generators.
H02K 1/04 - Details of the magnetic circuit characterised by the material used for insulating the magnetic circuit or parts thereof
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
F03G 7/00 - Mechanical-power-producing mechanisms, not otherwise provided for or using energy sources not otherwise provided for
H02K 16/04 - Machines with one rotor and two stators
Specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine can be effective for the treatment of progressive forms of Multiple Sclerosis, especially Primary Progressive Multiple Sclerosis and/or Secondary Progressive Multiple Sclerosis. Methods of treatment can be based on specific oral dosings, specific oral dosage forms, and/or specific oral dose regimens including Cladribine.
A61K 31/7076 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
The present invention relates to ionizable lipids for use in lipid nanoparticles, lipid nanoparticle formulations comprising these ionizable lipids, alone or in combination with other lipids and/or polymers. The lipid nanoparticles formulations may be formulated with nucleic acids for their delivery to target tissues after administration, in particular after parenteral administration such as intravenous, intramuscular, subcutaneous or intratumoral administration.
C07C 275/50 - Y being a hydrogen or an acyclic carbon atom
C07D 211/58 - Nitrogen atoms attached in position 4
C07D 295/067 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
C07F 7/18 - Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
A61K 48/00 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseasesGene therapy
C12N 15/88 - Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using liposome vesicle
SYNTHESIS ROUTE FOR PREPARING 8-(1,3-DIMETHYL-1H-PYRAZOL-4-YL)-1-(SA)-(3-FLUORO-5-METHOXY-PYRIDIN-4-YL)-7-METHOXY-3-METHYL-1,3-DIHYDRO-IMIDAZO[4,5-C]QUINOLIN-2-ONE
The invention relates to a random copolymer of structure (A), comprising a repeat unit of structure (I), a repeat unit of structure (II), two end group R3 and R4, wherein end group R3, is a moiety of structure (IIIa), and is either a C-1 to C-8 alkyl, or is a moiety of structure (III), and end group end group R4, is a moiety derived from termination of anionic polymerization, and is either selected from the group consisting of H, a C-1 to C-8 alkyl, C-1 to C-8 alkylcarbonyl, a C-1 to C-8 trialkylsilyl, a C-1 to C-8 dialkylsilyl, a C-1 to C-8 monoalkylsilyl, silane, and a benzylic moiety, or is a moiety of structure (IV), and where both R3 and R4 cannot, simultaneously, be respectively selected from a moiety of structure (III), and a moiety of structure (IV), and either R3 is a moiety of structure (III) or R4 is or a moiety of structure (IV). This invention also pertains to composition comprising this copolymer and an organic spin casting solvent and the use of this composition to form a grafted neutral layer for use in DSA processing.
G03F 7/11 - Photosensitive materials characterised by structural details, e.g. supports, auxiliary layers having cover layers or intermediate layers, e.g. subbing layers
C08F 220/18 - Esters of monohydric alcohols or phenols of phenols or of alcohols containing two or more carbon atoms with acrylic or methacrylic acids
One aspect of this invention is a photoresist composition comprising a thiol derivatives where the thiol moiety is attached to an SP2 carbon which is part of ring which has structures (H1), (H2) (H3), or (H4), and where this thiol additive is present in a range of about 0.5 wt. % to about 3 wt. % of total solids. Another aspect of this invention is to use this photoresist composition on a metal substrate a patterned photoresist which is use as a etch mask in anisotropic wet chemical etching of the metal substate to produce a patterned metallic substrate. Yet Another aspect of this invention is a composition which comprises the above-described thiol derivatives in a spin casting solution and the process of treating a metal substrate which allows overlaid patterned photo resist to be used as an etch mask for wet chemical etching to affect anisotropic etching of the metal substate to also generate patterned metallic substate.
One aspect of this invention is a photoresist composition comprising a thiol derivatives where the thiol moiety is attached to an SP2 carbon which is part of ring which has structures (H1), (H2) (H3), or (H4), and where this thiol additive is present in a range of about 0.5 wt. % to about 3 wt. % of total solids. Another aspect of this invention is to use this photoresist composition on a metal substrate a patterned photoresist which is use as a etch mask in anisotropic wet chemical etching of the metal substate to produce a patterned metallic substrate. Yet Another aspect of this invention is a composition which comprises the above-described thiol derivatives in a spin casting solution and the process of treating a metal substrate which allows overlaid patterned photo resist to be used as an etch mask for wet chemical etching to affect anisotropic etching of the metal substate to also generate patterned metallic substate.
The present application relates to a water purification system capable of providing ultrapure water for laboratory applications, comprising at least one water connection for supplying the system with feed water, for example tap water, to be purified, at least one pre-purification unit for pre-purifying the tap water, and at least one post-purification unit for post-purifying the pre-purified water. Furthermore, the present application relates to a laboratory comprising such water purification system. In addition, the present application relates to a method of producing purified water, particularly ultrapure water.
C02F 9/20 - Portable or detachable small-scale multistage treatment devices, e.g. point of use or laboratory water purification systems
C02F 1/00 - Treatment of water, waste water, or sewage
C02F 1/28 - Treatment of water, waste water, or sewage by sorption
C02F 1/32 - Treatment of water, waste water, or sewage by irradiation with ultraviolet light
C02F 1/44 - Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
C02F 1/469 - Treatment of water, waste water, or sewage by electrochemical methods by electrochemical separation, e.g. by electro-osmosis, electrodialysis, electrophoresis
In various embodiments, the present invention provides a process for separating target proteins from non-target proteins in a sample comprising increasing the concentration of the target proteins and non-target proteins in the sample and subsequently delivering the concentrated sample to a chromatography device. In other embodiments, the invention relates to a process for increasing the capacity of a chromatography device for a target protein by delivering a concentrated sample comprising the target protein to a chromatography device.
Liquid-crystalline media comprising one or more mesogenic compounds of formula I
Liquid-crystalline media comprising one or more mesogenic compounds of formula I
Liquid-crystalline media comprising one or more mesogenic compounds of formula I
and one or more dichroic dyes, and switching elements and window elements containing the LC materials. Also, the use of the liquid-crystalline media in devices for regulating the passage of energy from an outside space into an inside space, for example in switchable windows for solar energy control in smart buildings and vehicles with energy efficiency and improved comfort.
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/32 - Non-steroidal liquid crystal compounds containing condensed ring systems, i.e. fused, bridged or spiro ring systems
G02F 1/137 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering
G02F 1/139 - Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulatingNon-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells characterised by the electro-optical or magneto-optical effect, e.g. field-induced phase transition, orientation effect, guest-host interaction or dynamic scattering based on orientation effects in which the liquid crystal remains transparent
76.
RESIST COMPOSITION, METHOD FOR MANUFACTURING RESIST FILM, AND METHOD FOR MANUFACTURING DEVICE
The present invention relates to a compound of formula (I), to its use in electronic devices, to methods for producing said compound, and to electronic devices containing the compound.
H10K 85/60 - Organic compounds having low molecular weight
C07C 211/61 - Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton with at least one of the condensed ring systems formed by three or more rings
C07D 209/86 - CarbazolesHydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
C07D 219/02 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with only hydrogen, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
C07D 265/38 - [b, e]-condensed with two six-membered rings
09 - Scientific and electric apparatus and instruments
38 - Telecommunications services
42 - Scientific, technological and industrial services, research and design
45 - Legal and security services; personal services for individuals.
Goods & Services
Artificial intelligence software. Providing access to and leasing access time to computer
databases. Software as a Service [SaaS]. Licensing of computer software.
Probe holder for a bioreactor or other container or vessel, functioning as a base platform or stand to hold a sensor or probe, such as a Raman probe, in its an open position to be sterilized as part of an assembly including the sensor attached to a housing or container with an aseptic connector. The holder aids the user in positioning the sensor or probe at least partially within or in fluid communication with the interior of the bioreactor or vessel and holding and/or locking it in position during the use of the sensor or probe.
The new media exhibit a ferroelectric nematic phase preferably at ambient temperature. They preferably comprise one or more compounds selected from the group of compounds of formulae IA, IB and IC,
The new media exhibit a ferroelectric nematic phase preferably at ambient temperature. They preferably comprise one or more compounds selected from the group of compounds of formulae IA, IB and IC,
The new media exhibit a ferroelectric nematic phase preferably at ambient temperature. They preferably comprise one or more compounds selected from the group of compounds of formulae IA, IB and IC,
in which the variable groups have the meanings indicated in the text and in the claims. Use of the media for providing ferroelectric nematic materials and a method of operation of an electro-optical device are presented. The media may be useful for energy-saving displays and electrical appliances.
C09K 19/20 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings linked by a chain containing carbon and oxygen atoms as chain links, e.g. esters
C09K 19/02 - Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
C09K 19/04 - Liquid crystal materials characterised by the chemical structure of the liquid crystal components
C09K 19/12 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing at least two benzene rings at least two benzene rings directly linked, e.g. biphenyls
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
83.
SILICON PRECURSOR COMPOUND IN ASYMMETRIC STRUCTURE, METHOD FOR PREPARING THE SAME, AND METHOD FOR PREPARING A SILICON-CONTAINING THIN FILM
The present invention relates to a silicon precursor compound in an asymmetric structure containing an alkoxide capable of preparing a silicon-containing thin film with high quality, to a method for preparing the same, and to a method for preparing a silicon-containing thin film using the silicon precursor compound in an asymmetric structure containing an alkoxide.
C23C 16/455 - Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the method of coating characterised by the method used for introducing gases into the reaction chamber or for modifying gas flows in the reaction chamber
Liquid-crystalline (LC) media having positive dielectric anisotropy and liquid-crystal displays (LCDs) containing these media, especially displays addressed by an active matrix and in particular energy efficient LC displays of the TN, PSTN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, HB-FFS, XB-FFS, PS-FFS, SA-HB-FFS, SA-XB-FFS, polymer stabilised SA-HB-FFS, polymer stabilised SA-XB-FFS, positive VA or positive PS-VA type. The media have an improved long-term stability against UV radiation and elevated temperatures.
C09K 19/34 - Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
C09K 19/30 - Non-steroidal liquid crystal compounds containing at least two non-condensed rings containing saturated or unsaturated non-aromatic rings, e.g. cyclohexane rings
The disclosed subject matter relates compounds of structure (I), and polymers of structure (II) having a polydispersity ranging from 1 to about 1.1, compositions comprising said polymers and a spin casting solvent, the process of forming a pinning layer selectively on metal with said composition and the process of using said pinning layers to affect chemoepitaxy directed self-assembly of an overlying block copolymer, and the subsequent process of pattern transfer of this self-assembled layer into a substrate by etching.
The disclosed subject matter relates compounds of structure (I), and polymers of structure (II) having a polydispersity ranging from 1 to about 1.1, compositions comprising said polymers and a spin casting solvent, the process of forming a pinning layer selectively on metal with said composition and the process of using said pinning layers to affect chemoepitaxy directed self-assembly of an overlying block copolymer, and the subsequent process of pattern transfer of this self-assembled layer into a substrate by etching.
C08F 4/629 - Catalysts containing a specific non-metal or metal-free compound organic
C08F 8/40 - Introducing phosphorus atoms or phosphorus-containing groups
C08F 30/02 - Homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
C08F 130/02 - Homopolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
C08F 230/02 - Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and containing phosphorus, selenium, tellurium or a metal containing phosphorus
C08L 43/02 - Homopolymers or copolymers of monomers containing phosphorus
C09D 133/12 - Homopolymers or copolymers of methyl methacrylate
C09D 143/02 - Homopolymers or copolymers of monomers containing phosphorus
C09J 143/02 - Homopolymers or copolymers of monomers containing phosphorus
C09J 185/02 - Adhesives based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing atoms other than silicon, sulfur, nitrogen, oxygen, and carbonAdhesives based on derivatives of such polymers containing phosphorus
86.
HOLDER FOR A FLUID CONNECTOR FITTING AND FLUID DISPENSER INCLUDING THE SAME
F16L 3/12 - Supports for pipes, cables or protective tubing, e.g. hangers, holders, clamps, cleats, clips, brackets substantially surrounding the pipe, cable or protective tubing comprising a member substantially surrounding the pipe, cable or protective tubing
B01L 3/00 - Containers or dishes for laboratory use, e.g. laboratory glasswareDroppers
A surface treatment for a membrane, having a cross-linkable diacrylate solution used to make the cross-linked coating comprises a solution of at least one of 2.4-3.4% Hydroxypropyl acrylate and 1.1-2.1% polyethylene glycol diacrylate; 2.5-3.5% Bisphenol A ethoxylate diacrylate; 3.0-4.0% Bisphenol A ethoxylate diacrylate and 1.5-2.5% Hydroxypropyl acrylate; 1.5-2.5% Hydroxypropyl acrylate and 2.0-3.0% Polyethylene glycol diacrylate; 0.25-2.5% 2-Hydroxy-3-phenoxypropyl acrylate and 2.0-5.0% Polyethylene glycol diacrylate; or 3.0-4.0% Bisphenol A ethoxylate diacrylate. A filtration device for use with biological fluid, having a membrane; and a cross-linked coating on the membrane to form a surface modification or treatment, wherein the cross-linked coating is formed from a coating solution comprising a cross-linkable diacrylate.
B01D 67/00 - Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
B01D 69/02 - Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or propertiesManufacturing processes specially adapted therefor characterised by their properties
B01D 71/40 - Polymers of unsaturated acids or derivatives thereof, e.g. salts, amides, imides, nitriles, anhydrides, esters
A liquid-crystal (LC) medium or LC material based on a mixture of polar compounds, its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the vertically aligned mode and/or the fringe-field switching mode, an LC display of the vertically aligned mode and/or the fringe-field switching mode comprising the LC medium, especially an energy-saving LC display, and a process of manufacturing the LC display.
A metal complex, a formulation comprising metal complex and a method for preparing a metal oxide optical layer using said formulation and metal complex. The obtained metal oxide optical layers are particularly suitable for applications in optical devices such as, for example, in augmented reality (AR) and/or virtual reality (VR) devices.
B01D 15/36 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
B01D 15/38 - Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups , e.g. affinity, ligand exchange or chiral chromatography
B01D 15/42 - Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
91.
ISOTROPIC THERMAL ATOMIC LAYER ETCH OF ZIRCONIUM AND HAFNIUM OXIDES
The disclosed and claimed subject matter relates to (1) a process for performing thermal atomic layer etching (ALE) of films that include ZrO2, HfO2, (Hf—Zr)O2 alloy or similar materials which does not require the use of plasmas or corrosive halogenating chemistries and (2) a metal-insulator-metal capacitor (MIMcap) with unique properties enabled by a unique dielectric processing method.
A method and a system for calibrating at least one software-based regression model used for optimizing sensor data of a Raman Spectroscopy Instrument used for measuring a target bioprocess wherein the at least one software-based regression model is run by a computer, comprising the following steps of Acquiring at least one batch of Raman spectra data of both an initial Raman-monitored bioprocess and the target bioprocess associated with off-line reference values for all required bioprocess parameters and conditions; Creating an optimized software-based model for the target bioprocess adapted for every monitored bioprocess parameter by using dimensionality reduction techniques and applying a machine-learning transfer-algorithm on the Raman spectra data and the off-line reference values of the initial bioprocess and the target bioprocess via the computer; and Using the optimized software-based models in the Raman sprectroscopy instrument for monitoring the target bioprocess.
G01N 21/27 - ColourSpectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands using photo-electric detection
An Interface System and a method for connecting hardware based data sources with a System for producing biochemical compounds comprising the following components: • An User Interface to configure the Interface System; • An Input Interface for receiving data from the hardware based data sources including at least one standard hardware connector; • At least one software based model configured to process the received data from the hardware based data sources to calculate biochemical process parameters for the system; • An Output Interface to provide the processed digital data provided by the at least one software based model to the System for producing biochemical compounds, including at least one standard hardware connector; and • At least one computer to host the User Interface, the model and control the input and output interfaces.
Crimping tools [machines or parts of machines]; pipes
[fitted parts of machines]; joints for tubes (metal -)
[parts of machines]. Crimping tools (hand operated -); hand-operated pipe
cutters.
The present application relates to methods for stabilizing a photoacid generator in a photoresist composition, photoresist compositions, and uses of photoresist compositions.
A method of manufacturing an acoustic wave device according to the present invention comprises the steps of: forming an electrode on a piezoelectric substrate; forming a protective layer frame body surrounding the electrode; forming a sacrificial layer on the electrode by applying a sacrificial liquid thereon; forming a protective layer lid body on the sacrificial layer; and heating and removing the sacrificial layer to form an air gap, wherein the sacrificial liquid comprises a polymer and a solvent, and the polymer has a glass transition temperature of from 0 to 180°C.
H03H 3/02 - Apparatus or processes specially adapted for the manufacture of impedance networks, resonating circuits, resonators for the manufacture of electromechanical resonators or networks for the manufacture of piezoelectric or electrostrictive resonators or networks
A method of manufacturing an acoustic wave device according to the present invention comprises the steps of: forming a sacrificial layer by applying a sacrificial liquid to a recessed part of a support substrate having the recessed part on an upper surface of the support substrate; bonding a piezoelectric substrate to an upper side of the support substrate; and heating and removing the sacrificial layer to form an air gap, wherein the sacrificial liquid comprises a polymer and a solvent, and the polymer has a glass transition temperature of from 0 to 180°C.
H03H 3/08 - Apparatus or processes specially adapted for the manufacture of impedance networks, resonating circuits, resonators for the manufacture of electromechanical resonators or networks for the manufacture of resonators or networks using surface acoustic waves
H03H 3/02 - Apparatus or processes specially adapted for the manufacture of impedance networks, resonating circuits, resonators for the manufacture of electromechanical resonators or networks for the manufacture of piezoelectric or electrostrictive resonators or networks
98.
NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
The present invention relates to new compounds (materials) and to organic electronic devices such as OLEDs (organic light emitting diodes) that contain these compounds, for example as hole transport materials or hole injection materials. The invention also relates to mixtures containing these new compounds.
The present invention relates to a new method for synthesizing a chemical compound, comprising at least a following step; (lx) Applying Suzuki-Coupling to a precursor compound represented by the following chemical formula (la1) in the presence of an organoboron compound containing a group selected from one or members of the group selected from a vinyl group, alkyl vinyl group having carbon atoms 3 to 5 and a vinyl alcohol group. The synthesized compound can be a kind of advanced material or high performance material, and can be used for Inkjet Adaptive Planarization composition. It can be used in the nanotechnology process to make semiconductor device/display device application, for example liquid crystal, quantum dot or OLED display fabricated on a substrate, and controlled by semiconductors.
C07C 1/32 - Preparation of hydrocarbons from one or more compounds, none of them being a hydrocarbon starting from compounds containing hetero atoms other than, or in addition to, oxygen or halogen
C07C 15/14 - Polycyclic non-condensed hydrocarbons all phenyl groups being directly linked
C07C 15/16 - Polycyclic non-condensed hydrocarbons containing at least two phenyl groups linked by one single acyclic carbon atom
C07C 41/30 - Preparation of ethers by reactions not forming ether-oxygen bonds by increasing the number of carbon atoms, e.g. by oligomerisation
C07C 43/285 - Ethers having an ether-oxygen atom bound to carbon atoms both belonging to six-membered aromatic rings having unsaturation outside the six-membered aromatic rings
100.
NEGATIVELY CHARGED SILICA PARTICLES, METHOD OF PRODUCING SUCH PARTICLES, COMPOSITIONS COMPRISING SUCH PARTICLES, AND A METHOD OF CHEMICAL-MECHANICAL POLISHING USING SUCH PARTICLES
The present application relates to negatively charged silica particles, to a method of producing such particles, and to compositions comprising such particles as well as to a method for chemical mechanical polishing.
